Skip to content
10-Q

Quarterly Report

MEREO BIOPHARMA GROUP PLC MREO

0001193125-25-178489

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 795.48M sh
Shares Diluted Q2 2025 · Jun 30, 2025 799.44M sh
Shares Diluted Q2 2025 · Jun 30, 2025 794.02M sh
Shares Diluted Q2 2025 · Jun 30, 2024 711.77M sh
Shares Diluted Q2 2025 · Jun 30, 2024 706.41M sh
Capex Q2 2025 · Jun 30, 2025 $20K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$15.98M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$15.9M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $56.13M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $69.8M
Stockholders Equity Q2 2025 · Jun 30, 2025 $54.18M
Stockholders Equity Q2 2025 · Mar 31, 2025 $60.08M
Stockholders Equity Q2 2025 · Dec 31, 2024 $60.97M
Stockholders Equity Q2 2025 · Jun 30, 2024 $78.65M
Stockholders Equity Q2 2025 · Mar 31, 2024 $42.84M
Stockholders Equity Q2 2025 · Dec 31, 2023 $50.54M
Current Liabilities Q2 2025 · Jun 30, 2025 $7.56M
Current Liabilities Q2 2025 · Dec 31, 2024 $13.85M
Total Liabilities Q2 2025 · Jun 30, 2025 $8.45M
Total Liabilities Q2 2025 · Dec 31, 2024 $15.42M
Current Assets Q2 2025 · Jun 30, 2025 $61.42M
Current Assets Q2 2025 · Dec 31, 2024 $74.76M
Total Assets Q2 2025 · Jun 30, 2025 $62.63M
Total Assets Q2 2025 · Dec 31, 2024 $76.39M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.03
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2025 −$0.02
Eps Basic Q2 2025 · Jun 30, 2025 −$0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Sga Expense Q2 2025 · Jun 30, 2025 $5.49M
Sga Expense Q2 2025 · Jun 30, 2025 $12.77M
Sga Expense Q2 2025 · Jun 30, 2024 $7.87M
Sga Expense Q2 2025 · Jun 30, 2024 $13.78M
Rd Expense Q2 2025 · Jun 30, 2025 $5.37M
Rd Expense Q2 2025 · Jun 30, 2025 $9.3M
Rd Expense Q2 2025 · Jun 30, 2024 $4.95M
Rd Expense Q2 2025 · Jun 30, 2024 $8.94M
Net Income Q2 2025 · Jun 30, 2025 −$14.62M
Net Income Q2 2025 · Jun 30, 2025 −$27.5M
Net Income Q2 2025 · Mar 31, 2025 −$12.89M
Net Income Q2 2025 · Jun 30, 2024 −$12.26M
Net Income Q2 2025 · Jun 30, 2024 −$21.21M
Net Income Q2 2025 · Mar 31, 2024 −$8.95M
Operating Income Q2 2025 · Jun 30, 2025 −$10.5M
Operating Income Q2 2025 · Jun 30, 2025 −$21.7M
Operating Income Q2 2025 · Jun 30, 2024 −$12.81M
Operating Income Q2 2025 · Jun 30, 2024 −$22.72M
Revenue Q2 2025 · Jun 30, 2025 $500K
Revenue Q2 2025 · Jun 30, 2025 $500K
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Stock Issued Q2 2025 · Feb 28, 2025 17.11M sh